Correlation Between Oncimmune Holdings and Mereo BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncimmune Holdings and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncimmune Holdings and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncimmune Holdings plc and Mereo BioPharma Group, you can compare the effects of market volatilities on Oncimmune Holdings and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncimmune Holdings with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncimmune Holdings and Mereo BioPharma.

Diversification Opportunities for Oncimmune Holdings and Mereo BioPharma

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Oncimmune and Mereo is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Oncimmune Holdings plc and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Oncimmune Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncimmune Holdings plc are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Oncimmune Holdings i.e., Oncimmune Holdings and Mereo BioPharma go up and down completely randomly.

Pair Corralation between Oncimmune Holdings and Mereo BioPharma

Assuming the 90 days trading horizon Oncimmune Holdings plc is expected to under-perform the Mereo BioPharma. But the stock apears to be less risky and, when comparing its historical volatility, Oncimmune Holdings plc is 1.08 times less risky than Mereo BioPharma. The stock trades about -0.01 of its potential returns per unit of risk. The Mereo BioPharma Group is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  88.00  in Mereo BioPharma Group on August 26, 2024 and sell it today you would earn a total of  284.00  from holding Mereo BioPharma Group or generate 322.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy93.79%
ValuesDaily Returns

Oncimmune Holdings plc  vs.  Mereo BioPharma Group

 Performance 
       Timeline  
Oncimmune Holdings plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncimmune Holdings plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Oncimmune Holdings is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Oncimmune Holdings and Mereo BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncimmune Holdings and Mereo BioPharma

The main advantage of trading using opposite Oncimmune Holdings and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncimmune Holdings position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.
The idea behind Oncimmune Holdings plc and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing